Skip to main content
SpringerLink
Log in

Potentiation of Host Resistance Against Microbial Infections by Lentinan and its Related Polysaccharides

  • Chapter
Microbial Infections

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 319))

Abstract

Cytotoxic anticancer agents are generally accompanied by severe side effects in a host, and reduce resistance against cancer and infectious diseases, especially by destroying lymphoid cells and bone marrow cells. As a result, many cancer patients die of various kinds of pneumonitis, septicemia, uremia or other secondary diseases. There are, however, reliable clinical evidence to support the existence of intrinsic resistance against cancer and infectious disease in the human body. An increase in this resistance may be one of the most important facets in the development of pharmaceutical therapy against such diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. G. Chihara, Y. Maeda, J. Hamuro, T. Sasaki and F. Fukuoka, Inhibition of mouse sarcoma 180 by polysaccharides from Lentinus edodes (Berk.) Sing., Nature 222:687 (1969).

    Article  PubMed  CAS  Google Scholar 

  2. G. Chihara, J. Hamuro, Y. Y. Maeda, Y. Arai and F. Fukuoka, Fractionation and purification of the polysaccharides with marked antitumor activity, especially lentinan from Lentinusedodes (Berk.) sing., an edible mushroom. Cancer Res. 30:2776 (1970).

    PubMed  CAS  Google Scholar 

  3. J. Hamuro, Y. Y. Maeda, Y. Arai, F. Fukuoka and G. Chihara, The significance of the higher structure of the polysaccharides, lentinan and pachymaran with regard to their antitumor activity. Chem. Biol. Interact. 3:69 (1971).

    Article  PubMed  CAS  Google Scholar 

  4. T. L. Bluhm and A. Sarco, The triple helical structure of lentinan, a linear β-(1–3)-D-glucan. Can. J. Chem. 55:293 (1977).

    Article  CAS  Google Scholar 

  5. H. Saito, T. Ohki and T. Sasaki, A 13C-nuclear magnetic resonance study of polysaccharide gels. Molecular architecture in the gels consisting of fungal, branched (1–3)-β-D-glucans (lentinan and schizophyllan) as manifested by conformational changes induced by sodium hydroxide, Carbohydrate Res. 74:227 (1979).

    Article  CAS  Google Scholar 

  6. J. Zakany, G. Chihara and J. Fachet, Effect of lentinan on tumor growth in murine allogeneic and syngeneic hosts, Int J Cancer 25:371 (1980).

    Article  PubMed  CAS  Google Scholar 

  7. T. Suga, T. Shiio, Y.Y. Maeda and G. Chihara, Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methyl-cholanthrene induced carcinogenesis, Cancer Res 44:5132 (1984).

    PubMed  CAS  Google Scholar 

  8. W. C. Rose, F.C. Reed III, P. Siminoff and W.T. Bradner, Immunotherapy of Madison 109 lung carcinoma and other murine cancer using lentinan, Cancer Res 44:1368 (1984).

    PubMed  CAS  Google Scholar 

  9. T. Suga, T. Yoshihama, Y. Tsuchiya, T. Shiio, Y. Y. Maeda and G. Chihara, Prevention of tumor metastasis and recurrence of DBA/2 MC.CS-T fibrosarcoma, MH-134 hepatoma and other murine tumors using lentinan. Int. J. Immunotherapy. 5:187 (1989).

    CAS  Google Scholar 

  10. T. Taguchi, H. Furue, T. Kimura, T. Kondo, T. Hattori, I. Ito and N. Ogawa, End-point result of a randomized controlled study on the treatment of gastrointestinal cancer with a combination of lentinan and chemotherapeutic agents, in: “Rationale of Biological Response Modifiers in Cancer Treatment”, T. Tsubura, T. Aoki and I. Urushizaki, eds., Excerpta Medica, Amsterdam (1985).

    Google Scholar 

  11. G. Chihara, Lentinan and its related polysaccharides as host defence potentiators: Their application to infectious diseases and cancer, in: “Immunotherapeutic Prospects of Infectious Diseases”, K.N. Masihi and W. Lange, eds., p. 9, Springer-Verlag, Heidelberg (1990).

    Chapter  Google Scholar 

  12. T. Kawamura and Y. Numasaki, Effect of lentinan to host resistance against Listeria infections, Proc Jpn Cancer Assoc 39:134 (1980).

    Google Scholar 

  13. K. Kanai, E. Kondo, P.J. Jacques and G. Chihara, Immunopotentiating effect of fungal glucans as revealed by frequency limitation of post-chemotherapy relapse in experimental mouse tuberculosis, Jpn J Med Sci Biol 33:283 (1980).

    PubMed  CAS  Google Scholar 

  14. K. Matsuo, K. Nomoto, S. Shimotori and K. Takeya, Depression of protective mechanisms against microorganisms in tumor-bearing mice and its restoration by adjuvants, Jpn J Cancer Res (Gann) 68:456 (1977).

    Google Scholar 

  15. D. L. Williams, J.W. Browder and N.R. DiLuzio, Immunotherapeutic modification of E. coli induced experimental peritonitis and bacteremia by glucan, Surgery 93:448 (1983).

    PubMed  CAS  Google Scholar 

  16. N. R. DiLuzio and D.L. Williams, Protective effect of glucan against systemic Staphylococcus aureus septicemia in normal and leukemic mice, Infect Immun 20:804 (1978).

    CAS  Google Scholar 

  17. J. A. Reynolds, M.D. Kastello, D.G. Hallington, C.L. Crabbs, C.L. Peters, J.L. Jemski, G.H. Scott and N.R. DiLuzio, Glucan induced enhancement of host resistance to selected infectious diseases, Infect Immun 30:51 (1980).

    PubMed  CAS  Google Scholar 

  18. C. Hamada, Inhibition effect of lentinan on tumorigenesis of adenovirus type 12 in mice, in: “Manipulation of Host Defense Mechanisms”, T. Aoki, I. Urushizaki and E. Tsubura, eds., p. 76, Excerpta Medica, Amsterdam (1981).

    Google Scholar 

  19. K.S.S. Chang, Lentinan-mediated resistance against VSV-encephalitis, Abelson virus-induced tumor, and trophoblastic tumor in mice, in: “Manipulation of Host Defence Mechanisms”, T. Aoki, I. Urushizaki and E. Tsubura, eds., p. 88, Excerpta Medica, Amsterdam (1981).

    Google Scholar 

  20. D. L. Williams and N.R. DiLuzio, Glucan induced modification of murine viral hepatitis, Science 200:67 (1980).

    Article  Google Scholar 

  21. T. S. Tochikura, H. Nakashima, Y. Kaneko, N. Kobayashi and N. Yamamoto, Suppression of human immunodeficiency virus replication by 3′-Azido-3′-deoxy-thymidine in various human hematopoietic cell lines in vitro: Augmentation of the effect by lentinan, Jpn J Cancer Res (Gann) 78:583 (1987).

    CAS  Google Scholar 

  22. M. Ito, M. Baba, A. Sato, R. Pauwels, E. DeClercq and S. Shigeta, Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro, Antiviral Res 7:361 (1987).

    Article  PubMed  CAS  Google Scholar 

  23. M. Ito, M. Baba, K. Hirabayashi, T. Matsumoto, M. Suzuki, S. Suzuki, S. Shigeta and E. DeClercq, In vitro activity of mannan sulfate, a novel sulfated polysaccharide, against human immunodeficiency virus type 1 and other enveloped viruses, Eur J Clin Microbiol Infect Dis 8: 171 (1989)

    Article  PubMed  CAS  Google Scholar 

  24. L. Biesert, H. Suhartono, I. Winkler, C. Meichsner, M. Heisberg, G. Hewlett, V. Klimetzek, K. Moiling, H.D. Schlunberger, E. Schrinner, H.D. Brede and H. Rubsamen-Waigmann, Inhibition of HIV and virus replication by polysulphated polyxylan: HOE/BAY 946, a new antiviral compound, AIDS 2:449 (1988).

    Article  PubMed  CAS  Google Scholar 

  25. O. Yoshida, H. Nakashima, T. Yoshida, Y. Kaneko, I. Yamamoto, K. Matsuzaki, T. Uryu and N. Yamamoto, Sulfation of the immunomodulating polysaccharide lentinan: a novel strategy for antivirals to human immunodeficiency virus (HIV), Biochem Pharmacol 37:2887 (1988).

    Article  PubMed  CAS  Google Scholar 

  26. Y. Kaneko, O. Yoshida, R. Nakagawa, T. Yoshida, M. Date, S. Ogihara, S. Shioya, Y. Matsuzawa, N. Nagashima, Y. Irie, T. Mimura, H. Shinkai, N. Yasuda, K. Matsuzaki, T. Uryu and N. Yamamoto, Inhibition of HIV-1 infectivity with curdlan sulfate in vitro, Biochem Pharmacol 39:793 (1990).

    Article  PubMed  CAS  Google Scholar 

  27. K. N. Brown, in: “Immunology of Parasitic Infections”, Blackwell Scientific Publication, Oxford, p. 268, (1976).

    Google Scholar 

  28. D. W. Dresser and J. M. Phillips, The orientation of the adjuvant activities of Salmonella typhosa lipopolysaccharide and lentinan. Immunol. 27:895 (1974).

    CAS  Google Scholar 

  29. G. Dennert and D. Tucker, Antitumor polysaccharide lentinan, A T-cell adjuvant, J Natl Cancer Inst 51:1727 (1973).

    PubMed  CAS  Google Scholar 

  30. J. E. Byram, A. Sher, J. DiPietro, F. von Lichtenberg, Potentiation of schistosome granuloma formation by lentinan — a T-cell adjuvant, Am J Pathol 94:201 (1979).

    PubMed  CAS  Google Scholar 

  31. D. O. Adams, The granulomatous inflammatory response: A review. Am J Pathol 84:164 (1976).

    PubMed  CAS  Google Scholar 

  32. T. R. White, R. C. A. Thompson, W. J. Penhale and G. Chihara, The effect of lentinan on the resistance of mice to Mesocrestoides corti. Parasitol Res 74:563 (1988).

    Article  PubMed  CAS  Google Scholar 

  33. M. Song and N. R. DiLuzio, Yeast glucan and immunotherapy of infectious diseases, in: “Lysosomes in Biology and Pathology” P. J. Jacques and I. B. Shaw, eds., North Holland Press, Amsterdam, (1979).

    Google Scholar 

  34. J. A. Cook, T. W. Holbrook and W. J. Dougherty, Prospective effect of glucan against visceral leishmaniasis in hamsters. Infect Immun 37:1261 (1982).

    PubMed  CAS  Google Scholar 

  35. I. W. Browder, D. L. Williams, A. Kitahama and N. R. DiLuzio, Modification of post-operative C albicans sepsis by glucan immunostimulation. Int J Immunopharmac 6:19 (1984).

    Article  CAS  Google Scholar 

  36. J. Hamuro and G. Chihara, Lentinan, a T-cell oriented immunopotentiator: Its experimental and clinical applications and possible mechanism of immune modulation, in: “Immune Modulation Agents and Their Mechanisms”, R. L. Fenichel and M. A. Chirigos, eds., Marcel Dekker, New York, (1985).

    Google Scholar 

  37. Y. Y. Maeda and G. Chihara, The effect of neonatal thymectomy on the antitumor activity of lentinan, carboxymethylpachymaran and zymosan, and their effect on various immune responses. Int J Cancer 11:153 (1973).

    Article  PubMed  CAS  Google Scholar 

  38. Y. Y. Maeda, J. Hamuro and G. Chihara, The mechanism of action of antitumor polysaccharides. The effect of antilymphocyte serum on the antitumor activity of lentinan. Int J Cancer 8:41 (1971).

    Article  PubMed  CAS  Google Scholar 

  39. Y. Akiyama, S. Kashima, T. Hayami, M. Izawa, K. Mitsugi and J. Hamuro, Immunological characteristics of antitumor polysaccharides, lentinan and its analogs, as immune adjuvants, in: “Manipulation of Host Defense Mechanisms”, T. Aoki, I. Urushizaki and E. Tsubura, eds., Excerpta Medica, Amsterdam, (1981).

    Google Scholar 

  40. S. Kashima, T. Hayami, R. Yoshimoto, M. Izawa and J. Hamuro, Augentation of lymphokine-mediated natural killer cell activation by antitumor polysaccharide lentinan. Int J Immunopharmacol 4:269 (1982).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ajinomoto Co., Inc., Tokyo, Japan

    Yutaro Kaneko

  2. Biotechnology Research Center, Teikyo University, Kawasaki, 216, Japan

    Goro Chihara

Authors
  1. Yutaro Kaneko
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Goro Chihara
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of South Florida, Tampa, Florida, USA

    Herman Friedman  & Thomas W. Klein  & 

  2. Teikyo University School of Medicine, Tokyo, Japan

    Hideyo Yamaguchi

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer Science+Business Media New York

About this chapter

Cite this chapter

Kaneko, Y., Chihara, G. (1992). Potentiation of Host Resistance Against Microbial Infections by Lentinan and its Related Polysaccharides. In: Friedman, H., Klein, T.W., Yamaguchi, H. (eds) Microbial Infections. Advances in Experimental Medicine and Biology, vol 319. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3434-1_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-3434-1_21

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6519-8

  • Online ISBN: 978-1-4615-3434-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation